Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2023

Genmab — Juni 2023

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    Riis7
    wrote on sidst redigeret af
    #490

    enig de har ikke udbytte med bikube, men det har Genmab så ik;-)

    1 Reply Last reply
    0
    • R Offline
      R Offline
      Riis7
      wrote on sidst redigeret af
      #491

      Link Preview Image
      Siden kunne ikke findes | Euroinvestor

      favicon

      Euroinvestor (www.euroinvestor.dk)

      1 Reply Last reply
      0
      • K Offline
        K Offline
        Klarussen
        wrote on sidst redigeret af
        #492

        Halli Hallo. Man vender lige ryggen til og wups så har vi sørme en grøn dag til forandring 🙂

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #493

          😉

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #494

            Video opdatering: Det har ikke stået stille på nyhedsfronten, når det gælder flere af de populære pharma- og biotekselskaber på ProInvestor.com. Først og fremmest om EMA's ønske om undersøgelse af kræftrisikoen i to af Novo Nordisks produkter - er der grund til at være nervøs? Nyheden smitter også af på Zealand Pharmas aktiekurs. ALK-Abellós direktør går af i kølvandet på et dårligt kvartalsregnskab. Og hvad sker der med kursen på Genmab? . https://www.proinvestor.com/boards/113379

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Pensionisten
              wrote on sidst redigeret af
              #495

              Genmab slutter rigtigt pænt i USA - omregnet kurs 2616. Så heller ingrn panik over there. 🙂

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #496

                Just a moment...

                favicon

                (firstwordpharma.com)

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #497

                  Shortpositioner på danske aktier https://www.proinvestor.com/boards/113385

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    Klarussen
                    wrote on sidst redigeret af
                    #498

                    Tid til defensive aktier igen?

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      Klarussen
                      wrote on sidst redigeret af
                      #499

                      Genmab meget stabilt på short 0,43%

                      1 Reply Last reply
                      0
                      • R Offline
                        R Offline
                        Riis7
                        wrote on sidst redigeret af
                        #500

                        Kan Genmab ikke stige 2 dage i træk:-) kom nu

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bikube
                          wrote on sidst redigeret af
                          #501

                          Jo det kan den da - bare se, hvad der skete for et år siden, vi skal bare have fundet det rigtige udgangspunkt. Hvad var det for øvrigt, der startede opturen 16.juni sidste år.

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Riis7
                            wrote on sidst redigeret af
                            #502

                            Det bliver nok ikke i dag;-)

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #503

                              EPCORE DLBCL-1 seems fully recruited. They are extending the duratoin of the trial by 4 years. Outcomes will now be measured for 5 years instead of the intended 2 years. How should i read this? Is this a requirement by the FDA? Or are they now thinking patients could still be active on Epco after 5 years instead of 2? https://classic.clinicaltrials.gov/ct2/history/NCT04628494?B=24&A=23&C=merged#StudyPageTop

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #504

                                GEN1042, 3009 and 3014 were also updated btw

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #505

                                  Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease https://www.frontiersin.org/articles/10.3389/fimmu.2023.1212007/full?utm_source=S-TWT&utm_medium=SNET&utm_campaign=ECO_FIMMU_XXXXXXXX_auto-dlvrit

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #506

                                    E L regarding EPCORE DLBCL-1 study must be because it works better than expected…….possibility for cures maybe. But if they cant file based on interim data then it kind of sucks.

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #507

                                      Her er det så vi savner en q&a. Vi er afhængige af om nogen spørger ind til det på cc. Hvid de først kan file på RR i 2028 bliver det en langtrækker med epco.

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #508

                                        I hope you are right @Sukkeralf . I do believe interim data can be sufficient for filing

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #509

                                          $XBI Big Biotech #Outflows Return
                                          ~$894M of net outflows
                                          This is the #second #largest week of outflows for the sector this year and marks
                                          the 19th week of outflows out of 25 total weeks in 2023. YTD net fund flow now stands
                                          at ~$7.2B in outflows. https://twitter.com/BiotechAnalysst/status/1672236857281716225

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper